follow-up

Last reviewed 07/2021

• men with prostate cancer who have chosen a watchful waiting regimen with no curative intent should normally be followed up in primary care in accordance with protocols agreed by the local urological cancer MDT and the relevant primary care organisation(s)
  • their PSA should be measured at least once a year
    
    
• if patient had radical treatment
  • check PSA levels for all men with prostate cancer who are having radical treatment at the earliest 6 weeks following treatment, at least every 6 months for the first 2 years and then at least once a year thereafter
    
    
• do not routinely offer DRE to men with localised prostate cancer while the PSA remains at baseline levels
  
  
• after at least 2 years
  • offer follow-up outside hospital (for example, in primary care) by telephone or secure electronic communications to men with a stable PSA who have had no significant treatment complications, unless they are taking part in a clinical trial that requires formal clinicbased follow-up
    • direct access to the urological cancer MDT should be offered and explained

Reference:

• NICE (January 2014). Prostate cancer: diagnosis and treatment